leadf
logo-loader
viewBioSig Technologies, Inc.

BioSig Technologies says its PURE EP System has been installed and first patient cases conducted at Memorial Hospital of South Bend, Indiana

"We are very pleased to commence our clinical operations at Memorial Hospital, an outstanding clinical site that is recognized nationally for its commitment to high-quality care and innovation"

BioSig Technologies, Inc. -
To date, more than 450 patient cases have been conducted with the PURE EP System by over 30 physicians across seven clinical sites

BioSig Technologies, Inc. (NASDAQ:BSGM) has announced that its PURE EP System has been installed and first patient cases conducted at Memorial Hospital of South Bend, part of Beacon Health System in South Bend, Indiana. 

In a statement, Kenneth L. Londoner, chairman, and CEO of BioSig Technologies said: “We are very pleased to commence our clinical operations at Memorial Hospital, an outstanding clinical site that is recognized nationally for its commitment to high-quality care and innovation. As we continue to learn more about the coronavirus and its detrimental effects on cardiovascular health, we realize that treating heart rhythm disorders has never been more important."

"We recently initiated commercial sales of the PURE EP System. Our team looks forward to helping as many physicians and patients as possible as we expand our clinical footprint and provide the infrastructure to achieve much more throughout 2021," he added.

READ: BioSig Technologies and its NeuroClear division sign research agreement with University of Minnesota

The PURE EP System evaluation at the Memorial Hospital of South Bend is being conducted under the leadership of Vinod Chauhan, M.D. and Deepak Gaba, M.D.

To date, more than 450 patient cases have been conducted with the PURE EP System by over 30 physicians across seven clinical sites.

BioSig is currently conducting patient cases under the clinical trial titled “Novel Cardiac Signal Processing System for Electrophysiology Procedures (PURE EP 2.0 Study)” at Texas Cardiac Arrhythmia Research Foundation (TCARF) in Austin, Texas, Mayo Clinic Florida Campus in Jacksonville, Florida, and Massachusets General Hospital in Boston, MA. 

BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals.

The company’s first product, the PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.

Contact the author at [email protected]

Quick facts: BioSig Technologies, Inc.

Price: 4.82 USD

NASDAQ:BSGM
Market: NASDAQ
Market Cap: $148.07 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioSig Technologies, Inc. named herein, including the promotion by the Company of BioSig Technologies, Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read